Janux Therapeutics Inc Financial Overview
Janux Therapeutics Inc's market cap is currently $857.11M. The company's EPS TTM is $-0.39; its P/E ratio is -8.51; Janux Therapeutics Inc is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.62. See an overview of income statement, balance sheet, and cash flow financials.
